Delcath Systems (DCTH) had the highest return between October 1, 2017 and February 28, 2018 by a US stock, returning 16,122.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Delcath Systems (DCTH) | 10/1/2017 - 2/28/2018 | 16,122.22% |
SurgePays (SURG) | 10/1/2017 - 2/28/2018 | 4,771.79% |
Quantum Computing (QUBT) | 10/1/2017 - 2/28/2018 | 3,900% |
Focus Universal (FCUV) | 10/1/2017 - 2/28/2018 | 895.98% |
MDxHealth SA ADR (MDXH) | 10/1/2017 - 2/28/2018 | 780% |
Avalo Therapeutics (AVTX) | 10/1/2017 - 2/28/2018 | 454.76% |
TON Strategy (TONX) | 10/1/2017 - 2/28/2018 | 435.29% |
Gyre Therapeutics (GYRE) | 10/1/2017 - 2/28/2018 | 399.01% |
Cronos (CRON) | 10/1/2017 - 2/28/2018 | 338.97% |
eXp World (EXPI) | 10/1/2017 - 2/28/2018 | 285.94% |
Aurora Cannabis (ACB) | 10/1/2017 - 2/28/2018 | 260.8% |
Nektar Therapeutics (NKTR) | 10/1/2017 - 2/28/2018 | 258.28% |
AnaptysBio (ANAB) | 10/1/2017 - 2/28/2018 | 249.44% |
argenx NV ADR (ARGX) | 10/1/2017 - 2/28/2018 | 240.73% |
DeFi Technologies (DEFT) | 10/1/2017 - 2/28/2018 | 237.84% |
CIMG (IMG) | 10/1/2017 - 2/28/2018 | 229.59% |
Viking Therapeutics (VKTX) | 10/1/2017 - 2/28/2018 | 211.44% |
Xunlei Ltd Adr (XNET) | 10/1/2017 - 2/28/2018 | 200.47% |
Lexaria Bioscience (LEXX) | 10/1/2017 - 2/28/2018 | 183.64% |
Fate Therapeutics (FATE) | 10/1/2017 - 2/28/2018 | 181.5% |
Madrigal Pharmaceuticals (MDGL) | 10/1/2017 - 2/28/2018 | 179.16% |
Gravity (GRVY) | 10/1/2017 - 2/28/2018 | 176.66% |
VerifyMe (VRME) | 10/1/2017 - 2/28/2018 | 176.22% |
Artelo Biosciences (ARTL) | 10/1/2017 - 2/28/2018 | 176% |
Fubotv (FUBO) | 10/1/2017 - 2/28/2018 | 174.76% |
